Applied Genetic Tech (AGTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -57,829 | -45,693 | -30,842 | -15,380 | -45,892 |
| Depreciation Amortization | 1,841 | 1,365 | 938 | 467 | 1,335 |
| Accounts payable and accrued liabilities | 497 | 571 | 420 | 262 | 83 |
| Other Working Capital | 3,859 | 4,386 | 2,105 | 1,236 | 2,085 |
| Other Operating Activity | 459 | 1,633 | 1,071 | 498 | 769 |
| Operating Cash Flow | $-51,173 | $-37,738 | $-26,308 | $-12,917 | $-41,620 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 40,008 | 20,508 | 8,008 | 7,004 | 13,596 |
| PPE Investments | -1,861 | -1,350 | -981 | -760 | -1,197 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -4,000 |
| Investing Cash Flow | $38,147 | $19,158 | $7,027 | $6,244 | $8,399 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 9,850 | N/A | N/A | N/A | 9,855 |
| Debt Repayment | -48 | -35 | -23 | -11 | -45 |
| Common Stock Issued | 70,065 | 69,935 | 201 | 43 | 35,204 |
| Other Financing Activity | -252 | -252 | -252 | -252 | -33 |
| Financing Cash Flow | $79,615 | $69,648 | $-74 | $-220 | $44,981 |
| Beginning Cash Position | 38,463 | 38,463 | 38,463 | 38,463 | 26,703 |
| End Cash Position | 105,052 | 89,531 | 19,108 | 31,570 | 38,463 |
| Net Cash Flow | $66,589 | $51,068 | $-19,355 | $-6,893 | $11,760 |
| Free Cash Flow | |||||
| Operating Cash Flow | -51,173 | -37,738 | -26,308 | -12,917 | -41,620 |
| Capital Expenditure | -1,861 | -1,350 | -981 | -760 | -1,197 |
| Free Cash Flow | -53,034 | -39,088 | -27,289 | -13,677 | -42,817 |